TOMOTHERAPY : INDICATIONS
Tomotherapy
is cleared by Food&Drug Administration (FDA) for clinical use in Canada
and US , and in Europe with CE mark ( reg. No. HD 60009874 0001 ). It is
now used at San Raffaele within clinical trials approved by Hospital Ethic
Committee .
Protocols have been developed and will be
developed for Metabolically Guided Tomotherapy with conventional
fractionation (30-35 fractions in total), with the support of the Ministry
of Health, together with protocols for Metabolically Guided Tomotherapy
with hypofractionation (3-20 fractions in total) with the support of
Lombardy Region. Therefore, all Patients are evaluated by a pool of
Radiation Oncologists and Nuclear Medicine Clinicians and put in specific
institutional protocols, if the requirements are met with.
Pathologies, currently treated, belong to
the following categories:
Lung tumors
Prostatic tumors
Head & Neck tumors
Pancreas tumors
Isolated lung metastases
Isolated liver metastases
Once
accepted, Patient is put in a specific protocol.